CD Genomics, a leading provider of genomic services, is proud to announce a groundbreaking advancement in microsatellite development that is set to transform the landscape of genetic research. Leveraging the power of next-generation sequencing (NGS), CD Genomics enables researchers to harness the full potential of microsatellite markers for a wide range of applications.
Microsatellites, also known as simple sequence repeats (SSRs), have long been recognized as essential molecular markers for genetic studies. However, traditional methods of microsatellite development have been hindered by laborious and time-consuming processes. With the introduction of NGS technologies, CD Genomics has revolutionized the field by offering a streamlined and cost-effective solution.
"The advent of NGS technologies has opened up new possibilities for researchers working with microsatellites," said the senior scientist at CD Genomics. "By leveraging the high-throughput capabilities of Illumina sequencing platforms, we can now generate millions of short fragment reads, which are then meticulously analyzed to identify potential microsatellite loci."
This NGS-based approach offers several distinct advantages over traditional techniques. It significantly increases the output, dramatically reduces the time and complexity associated with microsatellite development, and importantly, enables the exploration of non-model organisms – a challenge that has long plagued the field.
"One of the key benefits of our NGS-based method is its ability to work with a wide range of species, including those without a well-characterized genome," explained the senior scientist. "This opens up new avenues of research for our clients, allowing them to unlock the full potential of microsatellite markers for their species of interest."
The comprehensive workflow outlined by CD Genomics begins with the preparation of a DNA library and shotgun sequencing, followed by the analysis of the sequencing results to identify potential microsatellite loci. The team then synthesizes primers and selects the most promising microsatellite loci by testing them on several individuals to assess amplification and polymorphism.
"Our commitment to providing ready-to-use, guaranteed, and tested polymorphic SSRs sets us apart in the industry," he added. "We aim to identify at least 10 polymorphic loci for our clients, empowering them to overcome the limitations of traditional microsatellite development and propel their research forward."
Whether researchers are studying model organisms or exploring the uncharted territories of non-model species, CD Genomics' microsatellite development service offers a cutting-edge solution that can unlock new avenues of genetic research. By embracing the power of NGS technology, the company is poised to transform the way researchers approach the development and application of microsatellite markers.
About CD Genomics
CD Genomics is a leading provider of genomics services, offering cutting-edge solutions for researchers worldwide. With a commitment to excellence and innovation, CD Genomics is at the forefront of driving scientific progress in the field of genomics.
Contact
Address: Shirley, NY 11967, USA
Email: contact@cd-genomics.com
Comments
0 comment